Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Apr;35(4):479–483. doi: 10.1038/bjc.1977.71

Early central nervous system involvement in adults with acute non-myelogenous leukaemia.

T A Lister, J M Whitehouse, M E Beard, A Paxton, R L Brearley, L Brown, P F Wrigley, D Crowther
PMCID: PMC2025338  PMID: 265731

Abstract

Of 47 consecutive patients aged 15-60 years with acute non-myelogenous leukaemia (ANML) (40 acute lymphoblastic leukaemia (ALL); 5 acute Burkitt-like leukaemia (ABLL), 2 acute undifferentiated leukaemia (AUL) treated with a standard chemotherapy protocol (OPAL), 31 achieved complete remission (28/40(70%) of patients with ALL). CNS leukaemia occurred in 4/16 non-remitters, and in 6 patients who achieved complete remission (CR). CNS leukaemia occurred in all 5 patients with acute Burkitt-like leukaemia. 4/28 patients with ALL achieving CR had evidence of CSF involvement on cytocentrifuge examination shortly after CR. The apparent risk of early CNS disease suggests that prophylactic CNS therapy should be given early in the treatment of acute non-myelogenous leukaemia.

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aur R. J., Hustu H. O., Verzosa M. S., Wood A., Simone J. V. Comparison of two methods of preventing central nervous system leukemia. Blood. 1973 Sep;42(3):349–357. [PubMed] [Google Scholar]
  2. Aur R. J., Simone J. V., Hustu H. O., Verzosa M. S. A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer. 1972 Feb;29(2):381–391. doi: 10.1002/1097-0142(197202)29:2<381::aid-cncr2820290219>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  3. Clarkson B. D., Dowling M. D., Gee T. S., Cunningham I. B., Burchenal J. H. Treatment of acute leukemia in adults. Cancer. 1975 Aug;36(2):775–795. doi: 10.1002/1097-0142(197508)36:2+<775::aid-cncr2820360824>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. HEWLETT J. S., BATTLE J. D., Jr, BISHOP R. C., FOWLER W. M., SCHWARTZ S. O., HAGEN P. S., LOUIS J. PHASE II STUDY OF A-8103 (NSC-25154) IN ACUTE LEUKEMIA IN ADULTS. Cancer Chemother Rep. 1964 Nov;42:25–28. [PubMed] [Google Scholar]
  5. Pavlovsky S., Eppinger-Helft M., Sackmann Muriel F. Factors that influence the appearance of central nervous system leukemia. Blood. 1973 Dec;42(6):935–938. [PubMed] [Google Scholar]
  6. Sackmann Muriel F., Pavlovsky S., Peñalver J. A., Hidalgo G., Cebrian Bonesana A., Eppinger-Helft M., De Macchi G. H., Pavlovsky A. Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia. Cancer. 1974 Aug;34(2):418–426. doi: 10.1002/1097-0142(197408)34:2<418::aid-cncr2820340227>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  7. Simone J. V., Aur R. J., Hustu H. O., Verzosa M. Acute lymphocytic leukemia in children. Cancer. 1975 Aug;36(2):770–774. doi: 10.1002/1097-0142(197508)36:2+<770::aid-cncr2820360823>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  8. Wolk R. W., Masse S. R., Conklin R., Freireich E. J. The incidence of central nervous system leukemia in adults with acute leukemia. Cancer. 1974 Mar;33(3):863–869. doi: 10.1002/1097-0142(197403)33:3<863::aid-cncr2820330336>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES